Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3
Stock drops 6% as heavy AI spending and restructuring clash with investor expectations Meta (META) delivered a mixed third quarter, ...
Tag: News
Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance
Robust operational performance, $225 million in revenue, and expanded bonding capacity position Orion for sustained growth Orion Group Holdings (ORN), ...
Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers
Equinox, Solstice, and other next-generation systems aim to advance trillion-parameter AI models, quantum computing, and sovereign AI innovation Nvidia (NVDA) ...
Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips
Chipmaker aims to challenge Nvidia and AMD with energy-efficient AI servers and next-generation accelerators launching in 2026 Qualcomm (NASDAQ: QCOM) ...
Co-Diagnostics Expands Global Reach with New Saudi Joint Venture
CoMira Diagnostics to Localize PCR Manufacturing and Healthcare Innovation Across KSA and 18 MENA Countries Co-Diagnostics (CODX), a leading molecular ...
Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology
Collaboration aims to enhance transparency, efficiency, and patient safety through smart contract integration Datavault AI (DVLT), a leader in AI-powered ...
AMD Shares Surge as IBM Taps Its Chips for Quantum Computing Breakthrough
Partnership fuels investor optimism as IBM prepares to launch its first quantum computer by 2029 Shares of Advanced Micro Devices ...
Intel Surges After Strong Q3 Earnings Beat, But Manufacturing Challenges Remain
Chipmaker posts surprise profit and revenue growth amid AI-driven demand and government-backed investments Intel Corporation (INTC) saw its stock jump ...
Ford Beats Q3 Estimates but Cuts 2025 Outlook Following Supplier Fire
Detroit automaker posts record $50.5 billion in quarterly revenue while revising guidance due to aluminum supply disruption Ford Motor Company ...
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official ...
